Ashik Kurian analyst CITI

Currently out of the existing stock ratings of Ashik Kurian, 7 are a BUY (58.33%), 5 are a HOLD (41.67%).

Ashik Kurian

Work Performance Price Targets & Ratings Chart

Analyst Ashik Kurian, currently employed at CITI, carries an average stock price target met ratio of 60% that have a potential upside of 22.47% achieved within 345 days.

Ashik Kurian’s has documented 26 price targets and ratings displayed on 4 stocks. The coverage is on the Consumer Cyclical sector.

Most recent stock forecast was given on MRSN, Mersana Therapeutics at 28-Jul-2023.

Wall Street Analyst Ashik Kurian

Analyst best performing recommendations are on VNE (VEONEER).
The best stock recommendation documented was for GT (GOODYEAR TIRE & RUBBER CO) at 3/30/2020. The price target of $7.5 was fulfilled within 10 days with a profit of $1.58 (26.69%) receiving and performance score of 26.69.

Average potential price target upside

ALV Autoliv GT Goodyear Tire & Rubber Co MRSN Mersana Therapeutics VNE Veoneer

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 13-Oct-2021

$145

$34 (30.63%)

$150

1 months 11 days ago
(02-Feb-2026)

2/6 (33.33%)

$24.51 (20.34%)

77

Hold Since 25-Mar-2021

$129

$18 (16.22%)

$132

4 months 21 days ago
(20-Oct-2025)

25/28 (89.29%)

$12.23 (10.47%)

257

Hold Since 19-Oct-2020

$133

$22 (19.82%)

$124

4 months 21 days ago
(20-Oct-2025)

13/15 (86.67%)

$16.23 (13.90%)

220

Hold Since 10-Oct-2025

$133

$22 (19.82%)

$116

5 months 3 days ago
(10-Oct-2025)

1/2 (50%)

$18.3 (15.95%)

295

Buy Since 15-Apr-2025

$150

$39 (35.14%)

$135

5 months 3 days ago
(10-Oct-2025)

11/13 (84.62%)

$35.3 (30.78%)

157

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Ashik Kurian?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?